Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis

Pediatrics International

Volumn 53, Issue 3, 2011, Pages 363-367

  Tang, Ching Shen ^a   Wang, Chih Chien ^a   Huang, Ching Feng ^a   Chen, Shyi Jou ^a   Tseng, Min Hua ^a   Lo, Wen Tsung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

antimicrobial susceptibility; atopic dermatitis; children; Staphylococcus aureus; Taiwan

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CHILD; CONCURRENT INFECTION; ERMB GENE; GENE; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; DERMATITIS, ATOPIC; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TAIWAN;

EID: 79959708483     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03227.x     Document Type: Article

References (34)

1. Leung DY,. Infection in atopic dermatitis. Curr. Opin. Pediatr. 2003; 15: 399-404. (Pubitemid 37006350)
2. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P,. Microbial colonization and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 2004; 4: 373-8. (Pubitemid 39274078)
3. Baker BS,. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 2006; 144: 1-9.
4. Hoeger PH, Lenz W, Bouronnier A, Fournier JM,. Staphylococcal skin colonization in children with atopic dermatitis: Prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J. Infect. Dis. 1992; 165: 1064-8.
5. Hoeger PH,. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr. Allergy Immunol. 2004; 15: 474-7. (Pubitemid 39423020)
6. Wertheim HF, Melles DC, Vos MC, et al,. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005; 5: 751-62. (Pubitemid 41688980)
7. Chen SF,. Staphylococcus aureus decolonization. Pediatr. Infect. Dis. J. 2005; 24: 79-80.
8. Paintsil E,. Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: Trends and management. Curr. Opin. Pediatr. 2007; 19: 75-82. (Pubitemid 46115957)
9. Hanifin JM, Rajka G,. Diagnostic features of atopic eczema. Acta Dermatol. Venereol. Suppl. 1980; 92: 44-7.
10. Nakamura MM, Rohling KL, Shashaty M, Lu H, Tang YW, Edwards KM,. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr. Infect. Dis. J. 2002; 21: 917-22.
11. Creech CB II, Kernodle DS, Alsentzer A, Wilson C, Edwards KM,. Increasing rate of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr. Infect. Dis. J. 2005; 24: 617-21. (Pubitemid 40993616)
12. National Committee for Clinical Laboratory Standards. Methods for Disk Diffusion: Approved Standard M2-A8: Performance Standards for Antimicrobial Disk Susceptibility Tests. The Committee, Wayne, PA, 2003.
13. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: 14th Informational Supplement. NCCLS document M100-S14. The Committee, Wayne, PA, 2004.
14. Finlay JE, Miller LA, Poupard JA,. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother. 1997; 41: 1137-9. (Pubitemid 27194199)
15. Olsson-Liljequist B, Koljalg S, Karlsson I, Kronvall G,. Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus aureus. APMIS 2002; 110: 690-6. (Pubitemid 36005835)
16. Weisblum B, Demohn V,. Erythromycin-inducible resistance in Staphylococcus aureus: Survey of antibiotic classes involved. J. Bacteriol. 1969; 98: 447-52.
17. Hiramatsu K, Kihara H, Yokota T,. Analysis of borderline-resistant strains of methicillin-resistant Staphylococcus aureus using polymerase chain reaction. Microbiol. Immunol. 1992; 36: 445-53.
18. Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK,. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 1996; 26: 73-8. (Pubitemid 27013843)
19. Almer LS, Shortridge VD, Nilius AM, et al,. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 2002; 43: 225-32. (Pubitemid 34775077)
20. Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC,. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 1993; 31: 211-17. (Pubitemid 23092834)
21. Hamilton-Miller JM, Shah S,. Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J. Antimicrob. Chemother. 2000; 46: 941-9. (Pubitemid 32004637)
22. Siberry GK, Tekle T, Carroll K, Dick J,. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 2003; 37: 1257-60. (Pubitemid 37372517)
23. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J,. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob. Agents Chemother. 1999; 43: 1062-6. (Pubitemid 29214725)
24. Liu YC, Huang WK, Huang TS, Kunin CM,. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine. Lancet 1999; 354: 1360. (Pubitemid 29481639)
25. Chang SC, Shiu MN, Chen TJ,. Antibiotic usage in primary care units in Taiwan after the institution of national insurance. Diagn. Microbiol. Infect. Dis. 2001; 40: 137-43.
26. Lo WT, Lin WJ, Tseng MH, et al,. Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infect. Dis. 2007; 7: 51.
27. Bamberger DM, Boyd SE,. Management of Staphylococcus aureus infections. Am. Fam. Physician 2005; 72: 2474-81. (Pubitemid 43060628)
28. Stevens DL, Bisno AL, Chambers HF, et al,. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin. Infect. Dis. 2005; 41: 1373-406. (Pubitemid 41581713)
29. Gorwitz RJ,. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2007; 44: 785-7. (Pubitemid 46365301)
30. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y,. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch. Intern. Med. 1996; 156: 1109-12. (Pubitemid 26158068)
31. Lipsky BA, Pecoraro RE, Ahroni JH, Peugeot RL,. Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 1992; 11: 43-7.
32. Lever R, Hadley K, Downey D, Mackie R,. Staphylococcal colonisation in atopic dermatitis and effect of topical mupirocin therapy. Br. J. Dermatol. 1988; 119: 189-98.
33. Gilani SJK, Gonzalez M, Hussain I, Finlay AY, Patel GK,. Staphylococcus aureus re-colonization in atopic dermatitis: Beyond the skin. Clin. Exp. Dermatol. 2005; 30: 10-13. (Pubitemid 40188307)
34. K'dzierska A, Kapińska-Mrowiecka M, Czubak-Macugowska M, Wójcik K, K'dzierska J,. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Br. J. Dermatol. 2008; 159: 1290-9.